Cross Country Healthcare Inc
NASDAQ:CCRN

Watchlist Manager
Cross Country Healthcare Inc Logo
Cross Country Healthcare Inc
NASDAQ:CCRN
Watchlist
Price: 9.47 USD -0.53% Market Closed
Market Cap: $310.2m

Cross Country Healthcare Inc
Investor Relations

Cross Country Healthcare, Inc. engages in the provision of healthcare staffing and workforce management solutions. The company is headquartered in Boca Raton, Florida and currently employs 2,250 full-time employees. The company went IPO on 2001-10-25. The firm operates through two segments: Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment provides traditional staffing, recruiting, including temporary and permanent placement of travel and local nurse and allied professionals, managed services programs (MSP) services, education healthcare services, in-home care services, and outsourcing services. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Mar 4, 2026
AI Summary
Q4 2025

Revenue: Q4 revenue was $237 million, down 5% sequentially and 24% year-over-year; full-year revenue was $1.05 billion, down 22% from 2024.

Momentum: Management says the merger overhang is behind the company, weekly production has improved in early 2026, and travelers on assignment are rising month-to-month into Q2.

Margins & cost actions: Q4 gross margin was 20.3% (down 10 bps sequentially), SG&A has been cut materially (U.S. headcount down 21% year-to-date) and management redeployed savings into hiring revenue producers.

Technology strategy: Intellify (VMS/workforce platform) and Xperience (clinician app) are core growth initiatives — management plans to expand Intellify into home-based and education staffing and to license it to other firms.

Balance sheet & capital allocation: $109 million cash, no debt; repurchased >800,000 shares in December for $6.8 million and another 486,000 shares in Q1; management is open to disciplined tuck-ins, especially in home-based staffing and complementary tech.

Outlook: Q1 2026 revenue guidance $235–240 million, adjusted EBITDA $4–5 million (~2% margin), adjusted EPS loss $0.04–0.06; target to exit 2026 with revenue run rate north of $1 billion and adjusted EBITDA margin of 4%–5%.

One-time items: Company recorded a $78 million noncash impairment tied to intangible assets and received a $20 million merger termination payment that created a net acquisition/integration credit for the period.

Key Financials
Revenue (Q4 2025)
$237 million
Revenue (Full year 2025)
$1.05 billion
Gross profit (Q4 2025)
$48 million
Gross margin (Q4 2025)
20.3%
Selling, general & administrative expense (Q4 2025)
$51 million
Selling, general & administrative expense (Full year 2025)
$200 million
SG&A excluding nonrecurring severance (Q4 2025)
$43 million
Adjusted EBITDA (Q4 2025)
$4 million
Adjusted EBITDA (Full year 2025)
$27 million
Adjusted EBITDA margin (Q4 2025)
1.7%
Adjusted EBITDA margin (Full year 2025)
2.5%
Noncash impairment charge
$78 million
Merger termination payment (cash)
$20 million
Net interest income (Q4 2025)
$300,000
Net interest income (Full year 2025)
$1 million
Income tax expense (Q4 2025)
$12 million
Income tax expense (Full year 2025)
$11 million
Nurse & Allied revenue (Q4 2025)
$194 million
Local & per diem revenue (Q4 2025)
$19 million
Education staffing revenue (Q4 2025)
$18 million
Education staffing revenue (Full year 2025)
$71 million
Home-based staffing revenue (Q4 2025)
$34 million
Home-based staffing run rate
north of $140 million (annualized)
Physician staffing revenue (Q4 2025)
$43 million
Cash on hand (Q4 2025)
$109 million
Share repurchases (Dec 2025)
>800,000 shares repurchased for $6.8 million (2.5% of shares outstanding)
Cash from operations (Q4 2025)
$18 million
Cash from operations (Full year 2025)
$48 million
Days sales outstanding (Q4 2025)
58 days
Capital expenditures / cash used in investing (Q4 2025)
$2 million
Q1 2026 revenue guidance
$235 million to $240 million
Q1 2026 adjusted EBITDA guidance
$4 million to $5 million
Q1 2026 adjusted EPS guidance
loss of $0.04 to $0.06
Q1 2026 guidance assumptions
gross margin 19.5% to 20%, net interest income $300,000, depreciation & amortization $4 million, stock-based compensation $1.3 million, tax provision ~$400,000
Earnings Call Recording
Other Earnings Calls

Management

Mr. Kevin Cronin Clark
Co-Founder & Non-Executive Chairman of the Board
No Bio Available
Mr. John A. Martins
President, CEO & Director
No Bio Available
Mr. William J. Burns CPA, M.B.A.
Executive VP & CFO
No Bio Available
Ms. Susan E. Ball J.D., M.B.A., R.N.
Chief Administrative Officer, Executive VP, General Counsel & Secretary
No Bio Available
Mr. Marc S. Krug J.D., M.B.A.
Group President of Delivery
No Bio Available
Mr. James V. Redd III, CPA, M.B.A.
Senior VP & Chief Accounting Officer
No Bio Available
Mr. Phillip Lyn Noe
Chief Information Officer
No Bio Available
Mr. Joshua David Vogel
Vice President of Investor Relations
No Bio Available
Karen Varga-Sinka
Director of Corporate Communications
No Bio Available
Mr. Gerald Purgay
Chief Marketing Officer
No Bio Available

Contacts

Address
FLORIDA
Boca Raton
6551 Park Of Commerce Boulevard, N.W.
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett